Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis leads and Bristol lags on novel drug approvals
EP Vantage
Wed, 07/14/21 - 10:10 am
Tags:
Novartis, Bristol Myers Squibb, drug approvals, FDA
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:05 am
Tags:
patents, patent cliff, AbbVie, Humira, Merck, Keytruda, Bristol Myers Squibb, Revlimid, Pfizer, Eliquis, Regeneron, Eylea, JNJ, Stelara, Opdivo, GSK, Dolutegravir, Ibrance, Januvia, Eli Lilly, Trulicity, Novo Nordisk, Victoza, Amgen, Prolia, Xgeva, Novartis, Cosentyx, Takeda, Entyvio
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Motley Fool
Sun, 07/11/21 - 11:13 pm
Tags:
clinical trials, Novartis, Biogen, SAGE Therapeutics, uniQure, Pfizer, Roche
Big pharma leads the way in stock market resurgence
EP Vantage
Wed, 07/7/21 - 10:49 am
Tags:
Big Pharma, pharma stocks, Acadia Pharmaceuticals, AstraZeneca, Biogen, Eli Lilly, GSK, Merck, Moderna Therapeutics, Novartis, Sanofi, Provention Bio
Novartis to make Leqvio for U.S. in Austria to overcome FDA delay
Reuters
Tue, 07/6/21 - 11:04 am
Tags:
Novartis, Leqvio, inclisiran, drug manufacturing, FDA, Austria
Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: survey
Fierce Pharma
Wed, 06/30/21 - 12:09 am
Tags:
Novartis, Adakveo, Global Blood Therapeutics, Oxbryta, sickle cell disease, gene therapy
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
Tags:
clinical trials, Pfizer, Roche, idanacogene elaparvovec, Alexion, AstraZeneca, Ultomiris, AbbVie, Rinvoq, Novartis, sabatolimab
Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants its money back
Fierce Pharma
Mon, 06/28/21 - 06:53 pm
Tags:
Novartis, Genentech, California, Chiron
Novartis touts latest Zolgensma data as SMA competition against Biogen, Roche heats up
Fierce Pharma
Sun, 06/20/21 - 10:21 pm
Tags:
Novartis, SMA, spinal muscular atrophy, Zolgensma, Roche, Evresdi
Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation
Endpoints
Thu, 06/17/21 - 11:09 am
Tags:
Novartis, radiopharmaceuticals, breakthrough therapy, FDA, Lu-PSMA-617
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
Tags:
FDA, drug approvals, Argenx, Novartis, AstraZeneca, Astellas, UCB Pharma, Ascendis Pharma, ChemoCentryx, Axsome Therapeutics
Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen
Fierce Pharma
Tue, 06/15/21 - 11:41 pm
Tags:
Novartis, Amegen, Aimovig, migraines
EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH
Pharmaforum
Sat, 06/12/21 - 10:26 pm
Tags:
Novartis, iptacopan, clinical trials, PNH, EHA
BMS will file for earlier-line use of Breyanzi in lymphoma after trial win
Pharmaforum
Fri, 06/11/21 - 10:49 am
Tags:
Bristol Myers Squibb, CAR-T, Breyanzi, large B-cell lymphoma, Novartis, Gilead Sciences, FDA
Novartis extends operations at U.K. plant for another year, keeping some 200 workers on board
Fierce Pharma
Wed, 06/9/21 - 10:55 pm
Tags:
Novartis, UK, drug manufacturing
Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA
Xtalks
Tue, 06/8/21 - 12:19 pm
Tags:
Novartis, Zolgensma, SMA, gene therapy
Roche, Pfizer and Novartis earn top marks from cancer patient groups during pandemic: survey
Fierce Pharma
Mon, 06/7/21 - 08:29 pm
Tags:
cancer, patients, COVID-19, pandemic, Roche, Pfizer, Novartis
Under ‘threat’ of fines, Novartis sues HHS over drug pricing program
Endpoints
Mon, 06/7/21 - 11:14 am
Tags:
Novartis, HHS, drug pricing
#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle
Endpoints
Thu, 06/3/21 - 10:51 am
Tags:
Novartis, ASCO 2021, CAR-T, Kymriah, follicular lymphoma, Gilead Sciences, Yescarta
Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment
Biopharma Reporter
Thu, 06/3/21 - 12:11 am
Tags:
Novartis, Molecular Partners, ensovibep, COVID-19, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.